Filtricine
Dr. Lorenz advises Filtricine on medical strategy and clinical trial design. His expertise spans more than 20 years of drug development and clinical trial design. Previously, he held senior leadership positions at Johnson and Johnson, Cor Therapeutics, Orexigen, Catalyst Biosciences, and Corgentech. Dr. Lorenz earned his MD at Case Western Reserve University.
This person is not in any offices
Filtricine
Filtricine is a clinical-stage biotech company. Filtricine is developing a proprietary targeted nutrients deprivation (TND) technology to help patients living with cancer manage their diseases.